Author

Joshua M. Lang

Observed name: J. Lang

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center

Observed institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center

ORCID: 0000-0002-0943-8872

Observed ORCID: 0000-0002-0943-8872

OpenAlex ID: A5041708383

NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026

2026 · Daniel E. Spratt, Sandy Srinivas, et al. · Journal of the National Comprehensive Cancer Network · 11

1407P Real-world outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and tumors with androgen receptor (AR) 878/875 mutations

2022 · T.F. Stewart, R. Gedrich, et al. · Annals of Oncology · 2

Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer

2026 · Erolcan Sayar, Helen M. Richards, et al. · Molecular Cancer Research · 1

Erratum: Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma

2026 · Vincent T. Ma, Alice Y. Zhou, et al. · JCO Precision Oncology

Abstract 5715: Histone-modifying enzymes in androgen-deprived prostate cancer: EZH1 as a synergistic therapeutic target

2026 · Tanaya Purohit, Emily Schmitt, et al. · Cancer Research

Works count: 5

Citation count: 14

H-index: 2

I10-index: 1